Trials / Completed
CompletedNCT00994513
Effect of Alpha Lipoic Acid on Obesity Related Comorbidities
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 70 (estimated)
- Sponsor
- Augusta University · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
The major objective of this study is to conduct a double-blind, placebo-controlled, randomized clinical trial to assess whether oral alpha lipoic acid supplementation will decrease cardiovascular disease and type 2 diabetes risk in obese subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Alpha Lipoic Acid | 1200 mg/day |
| DIETARY_SUPPLEMENT | Placebo | 1200 mg/day |
Timeline
- Start date
- 2009-07-01
- Primary completion
- 2010-05-01
- Completion
- 2010-05-01
- First posted
- 2009-10-14
- Last updated
- 2010-09-24
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT00994513. Inclusion in this directory is not an endorsement.